DashboardPortfoliosWatchlistCommunityDiscoverScreener
Narratives
What's New
  • Global
  • United States
  • Australia
  • United Kingdom
  • Canada
  • India
  • China
  • Argentina
  • Austria
  • Bahrain
  • Bangladesh
  • Belgium
  • Bermuda
  • Botswana
  • Brazil
  • Bulgaria
  • Chile
  • Colombia
  • Croatia
  • Cyprus
  • Czech Republic
  • Denmark
  • Egypt
  • Estonia
  • Finland
  • France
  • Germany
  • Ghana
  • Greece
  • Hong Kong
  • Hungary
  • Iceland
  • Indonesia
  • Ireland
  • Israel
  • Italy
  • Ivory Coast
  • Jamaica
  • Japan
  • Jordan
  • Kenya
  • Kuwait
  • Latvia
  • Lithuania
  • Luxembourg
  • Malawi
  • Malaysia
  • Malta
  • Mauritius
  • Mexico
  • Morocco
  • Namibia
  • Netherlands
  • New Zealand
  • Nigeria
  • Norway
  • Oman
  • Pakistan
  • Palestinian Authority
  • Peru
  • Philippines
  • Poland
  • Portugal
  • Qatar
  • Romania
  • Russia
  • Saudi Arabia
  • Serbia
  • Singapore
  • Slovakia
  • Slovenia
  • South Africa
  • South Korea
  • Spain
  • Sri Lanka
  • Sweden
  • Switzerland
  • Taiwan
  • Tanzania
  • Thailand
  • Trinidad & Tobago
  • Tunisia
  • Turkey
  • Uganda
  • Ukraine
  • United Arab Emirates
  • Venezuela
  • Vietnam
  • Zambia
  • Zimbabwe
  • Any
  • Automobiles
  • Banks
  • Capital Goods
  • Commercial Services
  • Consumer Durables
  • Consumer Services
  • Diversified Financials
  • Energy
  • Consumer Retailing
  • Food, Beverage & Tobacco
  • Healthcare
  • Household
  • Insurance
  • Materials
  • Media
  • Pharmaceuticals & Biotech
  • Real Estate
  • Retail
  • Semiconductors
  • Software
  • Tech
  • Telecom
  • Transportation
  • Utilities
🌎  Switch to Global Market
Author Program NEW
  • Community
  • /
  • India
  • /
  • Healthcare

Healthcare Indian Community

Our community narratives are driven by numbers and valuation.

Author Program NEW

Healthcare Indian Investing Ideas

ASTERDM logo
Aster DM Quality Care
18.1% undervalued intrinsic discount

Analysts Raise Aster DM Healthcare Price Target as Profit Margins Improve and Valuation Increases

View narrative
AN
AnalystConsensusTarget
AnalystConsensusTarget
Updated 20 Aug
Read Narrative
LALPATHLAB logo
Dr. Lal PathLabs
Fairly Valued intrinsic discount

Ayushman Bharat And Chronic Trends Will Expand Diagnostics Access

View narrative
AN
AnalystConsensusTarget
AnalystConsensusTarget
Updated 22 Aug
Read Narrative
NH logo
Narayana Hrudayalaya
15.5% undervalued intrinsic discount

Integrated Care And Oncology Expansion Will Shape India's Future

View narrative
AN
AnalystConsensusTarget
AnalystConsensusTarget
Updated 22 Aug
Read Narrative
APOLLOHOSP logo
Apollo Hospitals Enterprise
8.6% undervalued intrinsic discount

700 New Beds And Digital Health Will Reshape Healthcare Delivery

View narrative
AN
AnalystConsensusTarget
AnalystConsensusTarget
Updated 14 Aug
Read Narrative
KIMS logo
Krishna Institute of Medical Sciences
10.7% undervalued intrinsic discount

New Facilities In India Will Unlock Rising Healthcare Demand

View narrative
AN
AnalystConsensusTarget
AnalystConsensusTarget
Updated 3 Sep
Read Narrative
NEPHROPLUS logo
Nephrocare Health Services
9.7% undervalued intrinsic discount
Updated

Dialysis Demand And International Expansion Will Support A Positive Long Term View

View narrative
AN
AnalystConsensusTarget
AnalystConsensusTarget
Updated 8 Sep
Read Narrative
NH logo
Narayana Hrudayalaya
2.9% overvalued intrinsic discount
Updated

Government Regulation And Evolving Care Models Will Squeeze Margins

View narrative
AN
AnalystLowTarget
AnalystLowTarget
Updated 5 Sep
Read Narrative
METROPOLIS logo
Metropolis Healthcare
8.3% overvalued intrinsic discount

Digital Testing Will Undermine Traditional Diagnostics Profitability

View narrative
AN
AnalystLowTarget
AnalystLowTarget
Updated 3 Sep
Read Narrative
ASTERDM logo
Aster DM Quality Care
10.8% undervalued intrinsic discount

Regulatory Pressures And Oversupply Will Undermine Indian Healthcare

View narrative
AN
AnalystLowTarget
AnalystLowTarget
Updated 3 Sep
Read Narrative
Load more narratives

Top Authors

7d
30d
90d
All time
AuthorViews
JO
John_Eric
Emerging Author
John_Eric
16.3k
TR
tripledub
Recommended Voice
tripledub
8.8k
FU
FundamentalFlow
Emerging Author
FundamentalFlow
5.8k
RI
Rick_Orford
Rick_Orford
5.8k
HE
HedgeY
Emerging Author
HedgeY
5.8k
View top authors

Top Community Watchlists

SI
singhappily
Beyond the Moon - 20 compelling space companies!20 companies • 12.2k views
PLTR logo
MNTS logo
SESG logo
+17
ST
steve_investor
Superinvestor Buys25 companies • 4.3k views
FPS logo
ARE logo
NSC logo
+22
SI
singhappily
Quiet Compounders - 20 Quality US Midcaps20 companies • 2.9k views
TRNO logo
TXRH logo
WING logo
+17
AR
artoflosing
AI's Hidden Toll Booth20 companies • 2.6k views
VICR logo
MOD logo
FN logo
+17
TI
tickersymbolyou
TSY's Top 30 Stocks - 202630 companies • 2.6k views
QCOM logo
AEHR logo
APLD logo
+27
View all

Make Better Investing Decisions Anywhere

Scan to download
Open AppStoreOpen Google Play
Chrome Web Store
Level 5, 320 Pitt Street, Sydney
Financial Data provided by S&P Global Market Intelligence LLC, analysis provided by Simply Wall Street Pty Ltd. Copyright © 2026, S&P Global Market Intelligence LLC. All rights reserved.
View Data Sources
Markets
  • US: NYSE & NASDAQ
  • UK: FTSE
  • Australia: ASX
  • India: NIFTY
  • Canada: TSX
  • South Africa: JSE
  • Japan: NIKKEI
  • South Korea: KOSPI
  • Germany: DAX
Investing Ideas
  • Undervalued Companies
  • Dividend Powerhouses
  • Insider Buying
  • Nuclear Energy
  • Autonomous Vehicles
  • Artificial Intelligence
  • Crypto and Blockchain
  • Cybersecurity
  • More ideas
Stock Communities
  • AstraZeneca
  • HSBC Holdings
  • Shell
  • Unilever
  • Diageo
  • Rio Tinto Group
  • RELX
  • BP
  • Barclays
Features & Tools
  • Portfolio Tracker
  • Stock Screener & Alerts
  • Narratives & Fair Values
  • Dividend Calculator
News & Discovery
  • Latest Stock News
  • Global Market Insights
  • The Foxhole
  • Investing Ideas
  • Community Narratives
  • What's New
Simply Wall St
  • Plans & Pricing
  • Advertising
  • About Us
  • Contact Us
  • Careers
  • Help Center
  • Learn Stock Investing
  • Affiliate Program
  • Business & Enterprise
  • Charlie AI
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
© 2026 Simply Wall Street Pty Ltd, US Design Patent #29/544/281, Community and European Design Registration #2845206
  • Terms and Conditions
  • Privacy Policy
  • AI Terms
  • Financial Services Guide